The comprehensive osteoarthritis test: a simple index for measurement of treatment effects in clinical trials

J Rheumatol. 2004 Jun;31(6):1180-6.

Abstract

Objective: To assess the measurement properties of a simple index of symptom severity in osteoarthritis (OA) of the hips and knees.

Methods: Both the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the proposed new Comprehensive Osteoarthritis Test (COAT) instrument were completed weekly by 125 subjects in the context of a randomized, 12-week, 3 parallel-arm clinical trial. The reliabilities of the various scales were assessed on a weekly basis by use of Cronbach's alpha coefficients. The validity of the COAT total scale was assessed by correlation with the WOMAC total scale on a weekly basis with correlation coefficients, and in terms of the correlations between subject-level intercepts and slopes over time. The relative responsiveness of the WOMAC and COAT total scales was assessed using a multilevel (longitudinal) multivariate (WOMAC, COAT) linear model.

Results: The WOMAC and COAT total scales were highly reliable (mean over weeks: WOMAC alpha = 0.98; COAT alpha = 0.97). The correlations between the WOMAC and COAT scales were very high (mean over weeks = 0.92; subject-level intercepts = 0.91, slopes = 0.88). The COAT total scale was significantly more responsive than the WOMAC total scale in the active treatment (34.8% improvement vs 26.8%; p = 0.002).

Conclusion: The COAT total scale is simple to administer, reliable, valid, and responsive to treatment effects.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Clinical Trials as Topic / methods
  • Disability Evaluation*
  • Female
  • Humans
  • Male
  • Osteoarthritis / diagnosis*
  • Osteoarthritis / drug therapy
  • Pain Measurement / methods*
  • Pain Measurement / standards
  • Reproducibility of Results
  • Severity of Illness Index*

Substances

  • Antirheumatic Agents